News & AnalysisPetDx snags $62m Series BSan Diego-based PetDx, a liquid biopsy company for pets, has raised $62 million in Series B funding.ByIris Dorbian10 December 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs